White label – Pompe disease - ClinicalTrials.eu

Study on the Effectiveness of Ianalumab for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

Not recruiting

2 1
Investigated Diseases:
- Hidradenitis
Investigated Drugs:
- Ianalumab
Study on NTLA-2002 for Adults with Hereditary Angioedema Using Ziclumeran and Lonvoguran

Not recruiting

1 1
Investigated Drugs:
- Lonvoguran
- Ziclumeran
Study on Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Patients with Good Control and Neuropsychiatric Concerns

Not recruiting

3 1 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
Study on Azithromycin and Doxycycline for Reducing Inflammation in Sarcoidosis Patients

Not recruiting

3 1 1 1
Investigated Drugs:
- Azithromycin
- Doxycycline
Study of Avapritinib for Children with Solid Tumors Linked to KIT or PDGFRA Signaling

Not recruiting

1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Avapritinib
Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Not recruiting

3 1 1
Investigated Drugs:
- Lebrikizumab
Study on the Effects of Pasireotide in Patients with Low Blood Sugar After Bariatric Surgery

Not recruiting

2 1
Investigated Drugs:
- Pasireotide Diaspartate
- Placebo
Study on Etrinabdione for Patients with Peripheral Arterial Disease: Evaluating Safety and Tolerability

Not recruiting

2 1 1
Investigated Diseases:
- Peripheral arterial occlusive disease
Investigated Drugs:
- Etrinabdione
Study on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response

Not recruiting

3 1 1
Investigated Drugs:
- Niraparib Tosilate Monohydrate
+6
Study of erdafitinib versus chemotherapy (gemcitabine or mitomycin) for patients with high-risk non-muscle-invasive bladder cancer with FGFR mutations who failed BCG therapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Bladder transitional cell carcinoma
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies